| Standardisation of spirometry MR Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, ... European respiratory journal 26 (2), 319-338, 2005 | 11427 | 2005 |
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management G Raghu, HR Collard, JJ Egan, FJ Martinez, J Behr, KK Brown, TV Colby, ... American journal of respiratory and critical care medicine 183 (6), 788-824, 2011 | 6103* | 2011 |
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management G Raghu, HR Collard, JJ Egan, FJ Martinez, J Behr, KK Brown, TV Colby, ... American journal of respiratory and critical care medicine 183 (6), 788-824, 2011 | 5981 | 2011 |
| Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper BR Celli, W MacNee, A Agusti, A Anzueto, B Berg, AS Buist, ... European Respiratory Journal 23 (6), 932-946, 2004 | 5722 | 2004 |
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary J Vestbo, SS Hurd, AG Agustí, PW Jones, C Vogelmeier, A Anzueto, ... American journal of respiratory and critical care medicine 187 (4), 347-365, 2013 | 5226 | 2013 |
| Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary CF Vogelmeier, GJ Criner, FJ Martinez, A Anzueto, PJ Barnes, ... American journal of respiratory and critical care medicine 195 (5), 557-582, 2017 | 2475 | 2017 |
| Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention MS Niederman, LA Mandell, A Anzueto, JB Bass, WA Broughton, ... American journal of respiratory and critical care medicine 163 (7), 1730-1754, 2001 | 2400 | 2001 |
| A randomized trial comparing lung-volume–reduction surgery with medical therapy for severe emphysema National Emphysema Treatment Trial Research Group New England Journal of Medicine 348 (21), 2059-2073, 2003 | 2222 | 2003 |
| An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias WD Travis, U Costabel, DM Hansell, TE King Jr, DA Lynch, AG Nicholson, ... American journal of respiratory and critical care medicine 188 (6), 733-748, 2013 | 2032 | 2013 |
| Sustainable development: economics and environment in the Third World D Pearce, E Barbier, A Markandya Routledge, 2013 | 1516 | 2013 |
| Understanding e-learning continuance intention: An extension of the Technology Acceptance Model JC Roca, CM Chiu, FJ Martínez International Journal of human-computer studies 64 (8), 683-696, 2006 | 1340 | 2006 |
| Azithromycin for prevention of exacerbations of COPD RK Albert, J Connett, WC Bailey, R Casaburi, JAD Cooper Jr, GJ Criner, ... New England Journal of Medicine 365 (8), 689-698, 2011 | 1189 | 2011 |
| Chronic obstructive pulmonary disease phenotypes: the future of COPD MLK Han, A Agusti, PM Calverley, BR Celli, G Criner, JL Curtis, LM Fabbri, ... American journal of respiratory and critical care medicine 182 (5), 598-604, 2010 | 1168 | 2010 |
| International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for … JB Orens, M Estenne, S Arcasoy, JV Conte, P Corris, JJ Egan, T Egan, ... The Journal of heart and lung transplantation 25 (7), 745-755, 2006 | 1117 | 2006 |
| Acute exacerbations of idiopathic pulmonary fibrosis HR Collard, BB Moore, KR Flaherty, KK Brown, RJ Kaner, TE King Jr, ... American journal of respiratory and critical care medicine 176 (7), 636-643, 2007 | 1073 | 2007 |
| Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials PMA Calverley, KF Rabe, UM Goehring, S Kristiansen, LM Fabbri, ... The Lancet 374 (9691), 685-694, 2009 | 949 | 2009 |
| Outcomes for COPD pharmacological trials: from lung function to biomarkers M Cazzola, W MacNee, FJ Martinez, KF Rabe, LG Franciosi, PJ Barnes, ... European Respiratory Journal 31 (2), 416-469, 2008 | 912 | 2008 |
| Analysis of the lung microbiome in the “healthy” smoker and in COPD JR Erb-Downward, DL Thompson, MK Han, CM Freeman, L McCloskey, ... PloS one 6 (2), e16384, 2011 | 752 | 2011 |
| Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer, ... American journal of respiratory and critical care medicine 198 (5), e44-e68, 2018 | 718 | 2018 |
| Histopathologic variability in usual and nonspecific interstitial pneumonias KR Flaherty, WD Travis, TV Colby, GB Toews, EA Kazerooni, BH Gross, ... American journal of respiratory and critical care medicine 164 (9), 1722-1727, 2001 | 705 | 2001 |
Jeffrey L. CurtisProfessor of Internal Medicine, University of Michigan Health SystemEmail verificata su umich.edu
